Todd C. Davis Salary and Compensation - Ligand Pharmaceuticals Incorporated CEO Salary 2025

In fiscal year 2025, Todd C. Davis, Chief Executive Officer of Ligand Pharmaceuticals Incorporated (LGND), received total compensation of $11.5 million.

Todd C. Davis's compensation breakdown includes: base salary of $725K, stock awards valued at $5.5 million, option awards of $4.4 million, non-equity incentive compensation of $764K, and other compensation of $22K.

Compared to fiscal year 2024, Todd C. Davis's total compensation decreased 11% from $12.9 million to $11.5 million.

Ligand Pharmaceuticals Incorporated (LGND) Executive Pay 2025

Ligand Pharmaceuticals Incorporated's top 3 named executive officers received combined total compensation of $19.6 million in fiscal year 2025.

The named executive officers disclosed in Ligand Pharmaceuticals Incorporated's 2025 proxy statement are:Todd C. Davis (Chief Executive Officer) with total compensation of $11.5 million, Tavo Espinoza (Chief Financial Officer) with total compensation of $4.4 million, and Andrew Reardon (Chief Legal Officer and Secretary) with total compensation of $3.7 million.